Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment

Abstract

Tumorigenicity-inhibiting compounds have been identified in our daily diet. For example, isothiocyanates (ITCs) found in cruciferous vegetables were reported to have potent cancer-prevention activities. The best characterized ITC is sulforaphane (SF). SF can simultaneously modulate multiple cellular targets involved in carcinogenesis, including (1) modulating carcinogen-metabolizing enzymes and blocking the action of mutagens; (2) inhibition of cell proliferation and induction of apoptosis; and (3) inhibition of neo-angiogenesis and metastasis. SF targets cancer stem cells through modulation of nuclear factor kappa B (NF-κB), Sonic hedgehog (SHH), epithelial-mesenchymal transition, and Wnt/β-catenin pathways. Conventional chemotherapy/SF combination was tested in several studies and resulted in favorable outcomes. With its favorable toxicological profile, SF is a promising agent in cancer prevention and/or therapy. In this article, we discuss the human metabolism of SF and its effects on cancer prevention, treatment, and targeting cancer stem cells, as well as providing a brief review of recent human clinical trials on SF.

Keywords

sulforaphane / isothiocyanates / cancer / chemoprevention / antineoplastic agent

References

[1] von MeyenfeldtM. Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs, 2005, 9(Suppl 2): S35-38

[2] SurhYJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer, 2003, 3(10): 768-780

[3] HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674

[4] MithenR, FaulknerK, MagrathR, et al.. Development of isothiocyanate-enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor Appl Genet, 2003, 106(4): 727-734

[5] HigdonJV, DelageB, WilliamsDE, et al.. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res, 2007, 55(3): 224-236

[6] VerhoevenDT, GoldbohmRA, van PoppelG, et al.. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev, 1996, 5(9): 733-748

[7] VoorripsLE, GoldbohmRA, VerhoevenDT, et al.. Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on diet and cancer. Cancer Causes Control, 2000, 11(2): 101-115

[8] VoorripsLE, GoldbohmRA, van PoppelG, et al.. Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study: The Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol, 2000, 152(11): 1081-1092

[9] FeskanichD, ZieglerRG, MichaudDS, et al.. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst, 2000, 92(22): 1812-1823

[10] GiovannucciE, RimmEB, LiuY, et al.. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev, 2003, 12(12): 1403-1409

[11] JosephMA, MoysichKB, FreudenheimJL, et al.. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer, 2004, 50(2): 206-213

[12] NeuhouserML, PattersonRE, ThornquistMD, et al.. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev, 2003, 12(4): 350-358

[13] JefferyEH, KeckAS. Translating knowledge generated by epidemiological and in vitro studies into dietary cancer prevention. Mol Nutr Food Res, 2008, 52(Suppl 1): S7-17

[14] DrewnowskiA, Gomez-CarnerosC. Bitter taste, phytonutrients, and the consumer: a review. Am J Clin Nutr, 2000, 72(6): 1424-1435

[15] BianchiniF, VainioH. Isothiocyanates in cancer prevention. Drug Metab Rev, 2004, 36(3–4): 655-667

[16] TortorellaSM, RoyceSG, LicciardiPV, et al.. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition. Antioxid Redox Signal, 2015, 22(16): 1382-1424

[17] BellL, WagstaffC. Glucosinolates, Myrosinase Hydrolysis Products, and Flavonols Found in Rocket (Eruca sativa and Diplotaxis tenuifolia). J Agric Food Chem, 2014, 62(20): 4481-4492

[18] ConawayCC, KrzeminskiJ, AminS, et al.. Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes. Chem Res Toxicol, 2001, 14(9): 1170-1176

[19] ShapiroTA, FaheyJW, WadeKL, et al.. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarkers Prev, 1998, 7(12): 1091-1100

[20] MatusheskiNV, JefferyEH. Comparison of the Bioactivity of Two Glucoraphanin Hydrolysis Products Found in Broccoli, Sulforaphane and Sulforaphane Nitrile. J Agric Food Chem, 2001, 49(12): 5743-5749

[21] LiangH, YuanQ. Natural sulforaphane as a functional chemopreventive agent: including a review of isolation, purification and analysis methods. Crit Rev Biotechnol, 2012, 32(3): 218-234

[22] ProchaskaHJ, SantamariaAB, TalalayP. Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci U S A, 1992, 89(6): 2394-2398

[23] WestLG, MeyerKA, BalchBA, et al.. Glucoraphanin and 4-hydroxyglucobrassicin contents in seeds of 59 cultivars of broccoli, raab, kohlrabi, radish, cauliflower, brussels sprouts, kale, and cabbage. J Agric Food Chem, 2004, 52(4): 916-926

[24] CramerJM, JefferyEH. Sulforaphane absorption and excretion following ingestion of a semi-purified broccoli powder rich in glucoraphanin and broccoli sprouts in healthy men. Nutr Cancer, 2011, 63(2): 196-201

[25] ClarkeJD, HsuA, RiedlK, et al.. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res, 2011, 64(5): 456-463

[26] JugeN, MithenRF, TrakaM. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci, 2007, 64(9): 1105-1127

[27] FaheyJW, ZhangY, TalalayP. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A, 1997, 94(19): 10367-10372

[28] PrakashB, AmuthavalliA, EdisonD, et al.. Novel indole derivatives as potential anticancer agents: Design, synthesis and biological screening. Med Chem Res, 2018, 27(1): 321-331

[29] PetriN, TannergrenC, HolstB, et al.. Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos, 2003, 31(6): 805-813

[30] ConawayCC, GetahunSM, LiebesLL, et al.. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr Cancer, 2000, 38(2): 168-178

[31] RungapamestryV, DuncanAJ, FullerZ, et al.. Effect of cooking brassica vegetables on the subsequent hydrolysis and metabolic fate of glucosinolates. Proc Nutr Soc, 2007, 66(1): 69-81

[32] VermeulenM, Klopping-KetelaarsIW, van den BergR, et al.. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem, 2008, 56(22): 10505-10509

[33] JonesRB, FrisinaCL, WinklerS, et al.. Cooking method significantly effects glucosinolate content and sulforaphane production in broccoli florets. Food Chem, 2010, 123(2): 237-242

[34] SahaS, HollandsW, TeucherB, et al.. Isothiocyanate concentrations and interconversion of sulforaphane to erucin in human subjects after consumption of commercial frozen broccoli compared to fresh broccoli. Mol Nutr Food Res, 2012, 56(12): 1906-1916

[35] WangGC, FarnhamM, JefferyEH. Impact of thermal processing on sulforaphane yield from broccoli (Brassica oleracea L. ssp. italica). J Agric Food Chem, 2012, 60(27): 6743-6748

[36] ZhangY, TangL. Discovery and development of sulforaphane as a cancer chemopreventive phytochermcal. Acta Pharmacol Sin, 2007, 28: 1343

[37] ZhangY. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis, 2000, 21(6): 1175-1182

[38] KenslerTW, WakabayashiN. Nrf2: friend or foe for chemoprevention?. Carcinogenesis, 2009, 31(1): 90-99

[39] ZhangY, KolmRH, MannervikB, et al.. Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem Biophys Res Commun, 1995, 206(2): 748-755

[40] ZhangY, CallawayEC. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J, 2002, 364(Pt1): 301-307

[41] CallawayEC, ZhangY, ChewW, et al.. Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates. Cancer Lett, 2004, 204(1): 23-31

[42] BrüsewitzG, CameronBD, ChasseaudLF, et al.. The metabolism of benzyl isothiocyanate and its cysteine conjugate. Biochem J, 1977, 162(1): 99-107

[43] HerrI, BuchlerMW. Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat Rev, 2010, 36(5): 377-383

[44] CramerJM, Teran-GarciaM, JefferyEH. Enhancing sulforaphane absorption and excretion in healthy men through the combined consumption of fresh broccoli sprouts and a glucoraphanin-rich powder. Br J Nutr, 2012, 107(9): 1333-1338

[45] Al JanobiAA, MithenRF, GasperAV, et al.. Quantitative measurement of sulforaphane, iberin and their mercapturic acid pathway metabolites in human plasma and urine using liquid chromatography-tandem electrospray ionisation mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2006, 844(2): 223-234

[46] YeL, Dinkova-KostovaAT, WadeKL, et al.. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim Acta, 2002, 316(1–2): 43-53

[47] HuR, HebbarV, KimB-R, et al.. In Vivo Pharmacokinetics and Regulation of Gene Expression Profiles by Isothiocyanate Sulforaphane in the Rat. J Pharmacol Exp Ther, 2004, 310(1): 263-271

[48] KhorTO, HuR, ShenG, et al.. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Cancer Res, 2006, 66(8 Supplement): 1316-1316

[49] CornblattBS, YeL, Dinkova-KostovaAT, et al.. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis, 2007, 28(7): 1485-1490

[50] LockEA, ReedCJ. Xenobiotic metabolizing enzymes of the kidney. Toxicol Pathol, 1998, 26(1): 18-25

[51] TangL, LiG, SongL, et al.. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs, 2006, 17(3): 297-305

[52] Lenzi M, Fimognari C, Hrelia P. Sulforaphane as a Promising Molecule for Fighting Cancer. In Proceedings of Advances in Nutrition and Cancer, Berlin, Heidelberg, 2014:207–223

[53] IyanagiT. Molecular Mechanism of Phase I and Phase II Drug-Metabolizing Enzymes: Implications for Detoxification. In International Review of Cytology, Academic Press, 2007, 260: 35-112

[54] DengJ, ZhaoL, ZhangNY, et al.. Anatoxin B1 metabolism: Regulation by phase I and II metabolizing enzymes and chemoprotective agents. Mutat Res, 2018, 778: 79-89

[55] BarceloS, GardinerJM, GescherA, et al.. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis, 1996, 17(2): 277-282

[56] BarceloS, MaceK, PfeiferAM, et al.. Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazo[4,5-f]quinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane. Mutat Res, 1998, 402(1–2): 111-120

[57] BaconJR, WilliamsonG, GarnerRC, et al.. Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis, 2003, 24(12): 1903-1911

[58] RendicS, GuengerichFP. Contributions of Human Enzymes in Carcinogen Metabolism. Chem Res Toxicol, 2012, 25(7): 1316-1383

[59] MaheoK, MorelF, LangouetS, et al.. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res, 1997, 57(17): 3649-3652

[60] Gross-SteinmeyerK, StapletonPL, TracyJH, et al.. Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci, 2010, 116(2): 422-432

[61] ZhouC, PoultonEJ, GrunF, et al.. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol, 2007, 71(1): 220-229

[62] KenslerTW. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect, 1997, 105(Suppl 4): 965-970

[63] Vargas-MendozaN, Morales-GonzalezA, Madrigal-SantillanEO, et al.. Antioxidant and Adaptative Response Mediated by Nrf2 during Physical Exercise. Antioxidants (Basel), 2019, 8(6): 196

[64] ChenY, ShertzerHG, SchneiderSN, et al.. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem, 2005, 280(40): 33766-33774

[65] HuR, XuC, ShenG, et al.. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (−/−) mice. Cancer Lett, 2006, 243(2): 170-192

[66] ThimmulappaRK, MaiKH, SrisumaS, et al.. Identification of Nrf2-regulated Genes Induced by the Chemopreventive Agent Sulforaphane by Oligonucleotide Microarray. Cancer Res, 2002, 62(18): 5196-5203

[67] WuL, JuurlinkBH. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens, 2001, 19(10): 1819-1825

[68] JiangZQ, ChenC, YangB, et al.. Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci, 2003, 72(20): 2243-2253

[69] BastenGP, BaoY, WilliamsonG. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis, 2002, 23(8): 1399-1404

[70] ZhangY, GordonGB. A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther, 2004, 3(7): 885-893

[71] Dinkova-KostovaAT, HoltzclawWD, KenslerTW. The role of Keap1 in cellular protective responses. Chem Res Toxicol, 2005, 18(12): 1779-1791

[72] KenslerTW, EgnerPA, AgyemanAS, et al.. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem, 2013, 329: 163-177

[73] HongF, FreemanML, LieblerDC. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol, 2005, 18(12): 1917-1926

[74] Dinkova-KostovaAT, HoltzclawWD, ColeRN, et al.. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A, 2002, 99(18): 11908-11913

[75] TaoS, Rojo de la VegaM, ChapmanE, et al.. The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol Carcinog, 2018, 57(2): 182-192

[76] ShoreyLE, MadeenEP, AtwellLL, et al.. Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane. Toxicol Appl Pharmacol, 2013, 270(1): 60-69

[77] Shishu, KaurIP. Inhibition of mutagenicity of food-derived heterocyclic amines by sulforaphane—a constituent of broccoli. Indian J Exp Biol, 2003, 41(3): 216-219

[78] SingletaryK, MacDonaldC. Inhibition of benzo[a] pyrene- and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells bydibenzoylmethane and sulforaphane. Cancer Lett, 2000, 155(1): 47-54

[79] BonnesenC, EgglestonIM, HayesJD. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res, 2001, 61(16): 6120-6130

[80] FimognariC, BertiF, Cantelli-FortiG, et al.. Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ Mol Mutagen, 2005, 46(4): 260-267

[81] GillsJJ, JefferyEH, MatusheskiNV, et al.. Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett, 2006, 236(1): 72-79

[82] KuroiwaY, NishikawaA, KitamuraY, et al.. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett, 2006, 241(2): 275-280

[83] ChiaoJW, ChungFL, KancherlaR, et al.. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol, 2002, 20(3): 631-636

[84] ShanY, SunC, ZhaoX, et al.. Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int J Oncol, 2006, 29(4): 883-888

[85] TangL, ZhangY. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr, 2004, 134(8): 2004-2010

[86] JacksonSJT, SingletaryKW. Sulforaphane Inhibits Human MCF-7 Mammary Cancer Cell Mitotic Progression and Tubulin Polymerization. Journal Nutr, 2004, 134(9): 2229-2236

[87] ParnaudG, LiP, CassarG, et al.. Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer, 2004, 48(2): 198-206

[88] PhamN-A, JacobbergerJW, SchimmerAD, et al.. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther, 2004, 3(10): 1239-1248

[89] SinghSV, Herman-AntosiewiczA, SinghAV, et al.. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem, 2004, 279(24): 25813-25822

[90] WangL, LiuD, AhmedT, et al.. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol, 2004, 24(1): 187-192

[91] Gamet-PayrastreL, LiP, LumeauS, et al.. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res, 2000, 60(5): 1426-1433

[92] WangM, ChenS, WangS, et al.. Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer Caco-2 cells. Chin J Physiol, 2012, 55(2): 134-144

[93] KimMR, ZhouL, ParkBH, et al.. Induction of G(2)/M arrest and apoptosis by sulforaphane in human osteosarcoma U2-OS cells. Mol Med Rep, 2011, 4(5): 929-934

[94] KimJH, Han KwonK, JungJY, et al.. Sulforaphane Increases Cyclin-Dependent Kinase Inhibitor, p21 Protein in Human Oral Carcinoma Cells and Nude Mouse Animal Model to Induce G(2)/M Cell Cycle Arrest. J Clin Biochem Nutr, 2010, 46(1): 60-67

[95] SuppipatK, ParkCS, ShenY, et al.. Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS One, 2012, 7(12): e51251-e51251

[96] JakubikovaJ, CerviD, OoiM, et al.. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica, 2011, 96(8): 1170-1179

[97] JacksonSJT, SingletaryKW. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis, 2004, 25(2): 219-227

[98] ReedJC. Apoptosis-targeted therapies for cancer. Cancer Cell, 2003, 3(1): 17-22

[99] ElmoreS. Apoptosis: a review of programmed cell death. Toxicol Pathol, 2007, 35(4): 495-516

[100] Gamet-PayrastreL, LumeauS, GascN, et al.. Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs, 1998, 9(2): 141-148

[101] JakubíkováJ, SedlákJ, MithenR, et al.. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol, 2005, 69(11): 1543-1552

[102] ChoiS, LewKL, XiaoH, et al.. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis, 2007, 28(1): 151-162

[103] SinghAV, XiaoD, LewKL, et al.. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis, 2004, 25(1): 83-90

[104] GingrasD, GendronM, BoivinD, et al.. Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett, 2004, 203(1): 35-43

[105] ChaudhuriD, OrsulicS, AshokBT. Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Mol Cancer Ther, 2007, 6(1): 334-345

[106] FimognariC, NusseM, BertiF, et al.. Sulforaphane modulates cell cycle and apoptosis in transformed and non-transformed human T lymphocytes. Ann N Y Acad Sci, 2003, 1010: 393-398

[107] FimognariC, NusseM, CesariR, et al.. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 2002, 23(4): 581-586

[108] MisiewiczI, SkupinskaK, Kasprzycka-GuttmanT. Sulforaphane and 2-oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L-1210 leukemia and ME-18 melanoma cells. Oncol Rep, 2003, 10(6): 2045-2050

[109] PappaG, LichtenbergM, IoriR, et al.. Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutat Res, 2006, 599(1–2): 76-87

[110] ParkHS, HanMH, KimGY, et al.. Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells. Food Chem Toxicol, 2014, 64: 157-165

[111] ParkSY, KimGY, BaeSJ, et al.. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep, 2007, 18(1): 181-187

[112] DeviJR, ThangamEB. Mechanisms of anticancer activity of sulforaphane from Brassica oleracea in HEp-2 human epithelial carcinoma cell line. Asian Pac J Cancer Prev, 2012, 13(5): 2095-2100

[113] ChoNP, HanHS, LeemDH, et al.. Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol, 2009, 45(8): 654-660

[114] ChoSD, LiG, HuH, et al.. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer, 2005, 52(2): 213-224

[115] SinghSV, SrivastavaSK, ChoiS, et al.. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem, 2005, 280(20): 19911-19924

[116] MoonDO, KimMO, KangSH, et al.. Sulforaphane suppresses TNF-alpha-mediated activation of NF-kappaB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett, 2009, 274(1): 132-142

[117] Herman-AntosiewiczA, JohnsonDE, SinghSV. Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res, 2006, 66(11): 5828-5835

[118] JeongWS, KimIW, HuR, et al.. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res, 2004, 21(4): 661-670

[119] XuC, ShenG, ChenC, et al.. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene, 2005, 24(28): 4486-4495

[120] RamirezMC, SingletaryK. Regulation of estrogen receptor alpha expression in human breast cancer cells by sulforaphane. J Nutr Biochem, 2009, 20(3): 195-201

[121] KimH, KimEH, EomYW, et al.. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res, 2006, 66(3): 1740-1750

[122] MatsuiTA, SowaY, YoshidaT, et al.. Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. Carcinogenesis, 2006, 27(9): 1768-1777

[123] MyzakMC, KarplusPA, ChungFL, et al.. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res, 2004, 64(16): 5767-5774

[124] MyzakMC, HardinK, WangR, et al.. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis, 2006, 27(4): 811-819

[125] MarksPA, RichonVM, RifkindRA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst, 2000, 92(15): 1210-1216

[126] UngerstedtJS, SowaY, XuWS, et al.. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci U S A, 2005, 102(3): 673-678

[127] TortorellaSM, RoyceSG, LicciardiPV, et al.. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition. Antioxid Redox Signal, 2015, 22(16): 1382-1424

[128] CuervoAM. Autophagy: Many paths to the same end. Mol Cell Biochem, 2004, 263(1): 55-72

[129] JiaL, DourmashkinRR, AllenPD, et al.. Inhibition of autophagy abrogates tumour necrosis factor α induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol, 1997, 98(3): 673-685

[130] KanematsuS, UeharaN, MikiH, et al.. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res, 2010, 30(9): 3381-3390

[131] BeaverLM, KuintzleR, BuchananA, et al.. Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer. J Nutr Biochem, 2017, 42: 72-83

[132] CarmelietP, JainRK. Angiogenesis in cancer and other diseases. Nature, 2000, 407: 249

[133] GoldmannE. The growth of malignant disease in main and the lower animals: with special reference to the vascular system. Lancet, 1907, 170(4392): 1236-1240

[134] AlgireGH, ChalkleyHW, LegallaisFY, et al.. Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants. J Natl Cancer Inst, 1945, 6(1): 73-85

[135] IdeAG. Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. AJR Am J Roentgenol, 1939, 42: 891-899

[136] GreenblattM, PhilippeSK. Tumor Angiogenesis: Transfilter Diffusion Studies in the Hamster by the Transparent Chamber Technique2. J Natl Cancer Inst, 1968, 41(1): 111-124

[137] EhrmannRL, KnothM. Choriocarcinoma: Transfilter Stimulation of Vasoproliferation in the Hamster Cheek Pouch—Studied by Light and Electron Microscopy2. J Natl Cancer Inst, 1968, 41(6): 1329-1341

[138] GuptaGK, MilnerL, LinshawMA, et al.. Urinary basic fibroblast growth factor: A noninvasive marker of progressive cystic renal disease in a child. Am J Med Genet, 2000, 93(2): 132-135

[139] NishidaN, YanoH, NishidaT, et al.. Angiogenesis in cancer. Vasc Health Risk Manag, 2006, 2(3): 213-219

[140] LenziM, FimognariC, HreliaP. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res, 2014, 159: 207-223

[141] CarmelietP. VEGF as a key mediator of angiogenesis in cancer. Oncology, 2005, 69(Suppl 3): 4-10

[142] BertlE, BartschH, GerhauserC. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther, 2006, 5(3): 575-585

[143] BaoY, WangW, ZhouZ, et al.. Benefits and risks of the hormetic effects of dietary isothiocyanates on cancer prevention. PLoS One, 2014, 9(12): e114764-e114764

[144] AsakageM, TsunoNH, KitayamaJ, et al.. Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis, 2006, 9(2): 83-91

[145] JacksonSJ, SingletaryKW, VenemaRC. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol, 2007, 46(2): 77-84

[146] NetlandPA, ZetterBR. GoldfarbRH. Tumor-Cell Interactions with Blood Vessels during Cancer Metastasis. Fundamental Aspects of Cancer, 1989, Dordrecht, Springer Netherlands: 84-97

[147] LiottaLA. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol, 1984, 117(3): 339-348

[148] FidlerIJ. Tumor Heterogeneity and the Biology of Cancer Invasion and Metastasis. Cancer Res, 1978, 38(9): 2651-2660

[149] LiottaLA. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res, 1986, 46(1): 1-7

[150] LiottaLA, TryggvasonK, GarbisaS, et al.. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 1980, 284: 67

[151] NicolsonGL. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta, 1982, 695(2): 113-176

[152] ThejassP, KuttanG. Antimetastatic activity of Sulforaphane. Life Sci, 2006, 78(26): 3043-3050

[153] ChambersAF, MatrisianLM. Changing Views of the Role of Matrix Metalloproteinases in Metastasis. J Natl Cancer Inst, 1997, 89(17): 1260-1270

[154] Stetler-StevensonWG, HewittR, CorcoranM. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol, 1996, 7(3): 147-154

[155] HaizhenZ, BowenJP. Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature. Curr Med Chem, 2006, 13(8): 849-862

[156] JeeHG, LeeKE, KimJB, et al.. Sulforaphane Inhibits Oral Carcinoma Cell Migration and Invasion In Vitro. Phytother Res, 2011, 25(11): 1623-1628

[157] KanematsuS, YoshizawaK, UeharaN, et al.. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep, 2011, 26(3): 603-608

[158] WangDX, ZouYJ, ZhuangXB, et al.. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3beta/beta-catenin signaling pathways. Acta Pharmacol Sin, 2017, 38(2): 241-251

[159] Bouhassira EE. The SAGE Encyclopedia of Stem Cell Research. Second Edition ed. Thousand Oaks, California, 2015, https://doi.org/10.4135/9781483347660

[160] ReyaT, MorrisonSJ, ClarkeMF, et al.. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414: 105

[161] LiY, ZhangT. Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts. Future Oncol, 2013, 9(8): 1097-1103

[162] KallifatidisG, RauschV, BaumannB, et al.. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut, 2009, 58(7): 949-963

[163] TangSN, FuJ, NallD, et al.. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer, 2012, 131(1): 30-40

[164] MunozP, IliouMS, EstellerM. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol, 2012, 6(6): 620-636

[165] CanettieriG, Di MarcotullioL, GrecoA, et al.. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat Cell Biol, 2010, 12(2): 132-142

[166] NakashimaH, NakamuraM, YamaguchiH, et al.. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res, 2006, 66(14): 7041-7049

[167] RodovaM, FuJ, WatkinsDN, et al.. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. PLoS One, 2012, 7(9): e46083

[168] LiSH, FuJ, WatkinsDN, et al.. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol Cell Biochem, 2013, 373(1–2): 217-227

[169] Ali KhanM, Kedhari SundaramM, HamzaA, et al.. Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells. Evid Based Complement Alternat Med, 2015, 2015: 412149

[170] IwatsukiM, MimoriK, YokoboriT, et al.. Epithelialmesenchymal transition in cancer development and its clinical significance. Cancer Sci, 2010, 101(2): 293-299

[171] LiuX, FanD. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. Curr Pharm Des, 2015, 21(10): 1279-1291

[172] SrivastavaRK, TangSN, ZhuW, et al.. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci (Elite Ed), 2011, 3: 515-528

[173] ShanY, ZhangL, BaoY, et al.. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J Nutr Biochem, 2013, 24(6): 1062-1069

[174] Fresno VaraJA, CasadoE, de CastroJ, et al.. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev, 2004, 30(2): 193-204

[175] ShenG, KhorTO, HuR, et al.. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res, 2007, 67(20): 9937-9944

[176] ValkenburgKC, GraveelCR, Zylstra-DiegelCR, et al.. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers (Basel), 2011, 3(2): 2050-2079

[177] GinestierC, HurMH, Charafe-JauffretE, et al.. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 2007, 1(5): 555-567

[178] LiY, ZhangT, KorkayaH, et al.. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res, 2010, 16(9): 2580-2590

[179] KatoM, SlackFJ. microRNAs: small molecules with big roles—C. elegans to human cancer. Biol Cell, 2008, 100(2): 71-81

[180] YuSL, ChenHY, ChangGC, et al.. MicroRNA Signature Predicts Survival and Relapse in Lung Cancer. Cancer Cell, 2008, 13(1): 48-57

[181] SeikeM, GotoA, OkanoT, et al.. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA, 2009, 106(29): 12085-12090

[182] IorioMV, CasaliniP, TagliabueE, et al.. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer, 2008, 44(18): 2753-2759

[183] CalinGA, DumitruCD, ShimizuM, et al.. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 2002, 99(24): 15524-15529

[184] CalinGA, CroceCM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene, 2006, 25: 6202

[185] VenturaA, JacksT. MicroRNAs and Cancer: Short RNAs Go a Long Way. Cell, 2009, 136(4): 586-591

[186] LiJ, HuangH, SunL, et al.. MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor. Clin Cancer Res, 2009, 15(12): 3998-4008

[187] LiuCJ, TsaiMM, HungPS, et al.. miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma. Cancer Res, 2010, 70(4): 1635-1644

[188] YangMH, LinBR, ChangCH, et al.. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene, 2011, 31: 2401

[189] LuYC, ChenYJ, WangHM, et al.. Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling. Cancer Prev Res, 2012, 5(4): 665-674

[190] YuCC, ChenYW, ChiouGY, et al.. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol, 2011, 47(3): 202-210

[191] LiuCM, PengCY, LiaoYW, et al.. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction. J Formos Med Assoc, 2017, 116(1): 41-48

[192] LiQ, YaoY, EadesG, et al.. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene, 2013, 33: 2589

[193] LiX, ZhaoZ, LiM, et al.. Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p. Biomed Pharmacother, 2018, 103: 473-481

[194] KallifatidisG, LabschS, RauschV, et al.. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther, 2011, 19(1): 188-195

[195] CorbinAS, AgarwalA, LoriauxM, et al.. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest, 2011, 121(1): 396-409

[196] LinLC, YehCT, KuoCC, et al.. Sulforaphane Potentiates the Efficacy of Imatinib against Chronic Leukemia Cancer Stem Cells through Enhanced Abrogation of Wnt/β-Catenin Function. J Agric Food Chem, 2012, 60(28): 7031-7039

[197] ChenH, LandenCN, LiY, et al.. Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane. J Oncol, 2013, 2013: 9

[198] WangX, LiY, DaiY, et al.. Sulforaphane improves chemotherapy efficacy by targeting cancer stem celllike properties via the miR-124/IL-6R/STAT3 axis. Sci Rep, 2016, 6: 36796

[199] ElkashtyOA, AshryR, ElghanamGA, et al.. Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas. Med Oncol, 2018, 35(9): 124

[200] FimognariC, NusseM, LenziM, et al.. Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat Res, 2006, 601(1–2): 92-101

[201] FimognariC, LenziM, SciuscioD, et al.. Combination of doxorubicin and sulforaphane for reversing doxorubicinresistant phenotype in mouse fibroblasts with p53Ser220 mutation. Ann N Y Acad Sci, 2007, 1095: 62-69

[202] KaminskiBM, SteinhilberD, SteinJM, et al.. Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. Curr Pharm Biotechnol, 2012, 13(1): 137-146

[203] DoszEB, JefferyEH. Commercially produced frozen broccoli lacks the ability to form sulforaphane. J Funct Foods, 2013, 5(2): 987-990

[204] HoughtonCA, FassettRG, CoombesJS. Sulforaphane: translational research from laboratory bench to clinic. Nutr Rev, 2013, 71(11): 709-726

[205] CipollaBG, MandronE, LefortJM, et al.. Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy. Cancer Prev Res, 2015, 8(8): 712-719

[206] KenslerTW, ChenJG, EgnerPA, et al.. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People’s Republic of China. Cancer Epidemiol Biomarkers Prev, 2005, 14(11Pt1): 2605-2613

[207] EgnerPA, ChenJG, WangJB, et al.. Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila), 2011, 4(3): 384-395

[208] KenslerTW, NgD, CarmellaSG, et al.. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis, 2012, 33(1): 101-107

[209] FaheyJW, WehageSL, HoltzclawWD, et al.. Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prev Res (Phila), 2012, 5(4): 603-611

[210] RiedlMA, SaxonA, Diaz-SanchezD. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol, 2009, 130(3): 244-251

[211] AlumkalJJ, SlottkeR, SchwartzmanJ, et al.. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest New Drugs, 2015, 33(2): 480-489

[212] Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer. Availabe online: https://ClinicalTrials.gov/show/NCT03182959 (accessed on May 2002)

[213] MyzakMC, TongP, DashwoodWM, et al.. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood), 2007, 232(2): 227-234

[214] TrakaM, GasperAV, MelchiniA, et al.. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One, 2008, 3(7): e2568

[215] HanlonN, ColdhamN, GielbertA, et al.. Repeated intake of broccoli does not lead to higher plasma levels of sulforaphane in human volunteers. Cancer Lett, 2009, 284(1): 15-20

[216] BahadoranZ, MirmiranP, HosseinpanahF, et al.. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. Eur J Clin Nutr, 2011, 65(8): 972-977

[217] ZhangZ, GarzottoM, DavisEW, et al.. Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial. Nutr Cancer, 2020, 72(1): 74-87

[218] Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue. Availabe online: https://clinicaltrials.gov/ct2/show/study/NCT00982319 (accessed on May 2020).

[219] TahataS, SinghSV, LinY, et al.. Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi. Cancer Prev Res (Phila), 2018, 11(7): 429-438

[220] TrakaMH, MelchiniA, Coode-BateJ, et al.. Transcriptional changes in prostate of men on active surveillance after a 12-mo glucoraphanin-rich broccoli intervention-results from the Effect of Sulforaphane on prostate Cancer Prevention (ESCAPE) randomized controlled trial. Am J Clin Nutr, 2019, 109(4): 1133-1144

[221] AtwellLL, ZhangZ, MoriM, et al.. Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy. Cancer Prev Res (Phila), 2015, 8(12): 1184-1191

[222] Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction. Availabe online: https://clinicaltrials.gov/ct2/show/NCT03934905?term=sulforaphane&rank=1 (accessed on May 2020).

[223] SuhN, LuyengiL, FongHH, et al.. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res, 1995, 15(2): 233-239